Medicine
Compro 25 mg suppository
Compro 25 mg suppository is a prescription medicine containing Prochlorperazine for rectal use, marketed by Padagis, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Prochlorperazine
- Brand
- Compro
- Strength
- 25 mg
- Dosage form
- Suppository
- Route
- Rectal
- Packs
- 12 packets, 2 suppositories, 6 suppositories
- Marketing authorisation holder
- Padagis
- Manufacturers
- PadagisPD-Rx Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05AB04 Prochlorperazine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 September 2000
- Identifiers
- RxCUI 198159, 284254DailyMed set ID b23b67eb-78b7-48eb-84ff-c95d3ce8683c, ea381bc5-0957-4c91-826a-0ff680cebaccNDC 55289-119, 0574-7226Application ANDA040246
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 12 packet in 1 carton / 1 suppository in 1 packet | 0574-7226-12 | Padagis | 1 September 2000 |
| 2 suppository in 1 bottle, plastic | 55289-119-02 | PD-Rx Pharmaceuticals | 22 December 2010 |
| 6 suppository in 1 bottle, plastic | 55289-119-06 | PD-Rx Pharmaceuticals | 18 January 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 October 1956 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Prochlorperazine 25 mg suppository.
Other strengths and forms of Prochlorperazine
Clinical summary
Prochlorperazine is a phenothiazine. It is available as tablets, injection and suppositories for oral, intramuscular and intravenous use. MedsAcross supplies Prochlorperazine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ProchlorperazineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Prochlorperazine Edisylate prescribing information (Civica) · U.S. National Library of Medicine, DailyMed
Need Compro 25 mg suppository for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.